210 RITUXIMAB MAINTENANCE AFTER NORDIC PROTOCOL (R‐MAXICHOP/HD‐ ARAC/ASCT) SIGNIFICANTLY PROLONGS SURVIVAL IN YOUNG MANTLE CELL LYMPHOMA PATIENTS P. Klener* | D. Salek | H. Mocikova | P. Blahovcova | R. Pytlik | A. Janikova | V. Prochazka | V. Campr | L. Boudova | R. Jaksa...
RITUXIMAB MAINTENANCE AFTER NORDIC PROTOCOL (R‐MAXICHOP/HD‐ARAC/ASCT) SIGNIFICANTLY PROLONGS SURVIVAL IN YOUNG MANTLE CELL LYMPHOMA PATIENTSTo better understand roles of microRNAs and their targets in development of lymphoproliferative disorders. The projects aims to identify networks of molecules involved...